DrugLib.com — Drug Information Portal

Rx drug information, pharmaceutical research, clinical trials, news, and more

Viramune (Nevirapine) - Current Clinical Trials


Viramune Related Clinical Trials

Pharmacokinetics Study on Nevirapine Resistance in Tanzania [Completed]

A Phase I Multiple Dose Pharmacokinetic Study of Nevirapine Extended Release (XR) in HIV-1 Infected Children. [Completed]

Nevirapine vs Ritonavir-boosted Lopinavir in ART Naive HIV-infected Adults in a Resource Limited Setting [Completed]

Efficacy and Safety of Concomitant Use of Nevirapine and Rifampicin With HIV-TB [Completed]

VENICE Study Nevirapine Full Dose/Dose Escalation [Completed]

Investigation of the Potential Pharmacokinetic Interaction Between Nevirapine (VIRAMUNE) and Ethinyl Estradiol/Norethindrone in HIV-1 Infected Women [Completed]

Bioequivalence Study of Pediatric Formulations to Treat HIV Infection [Active, not recruiting]

Nevirapine Drug Levels in HIV Positive Patients Also Receiving Rifampicin for Tuberculosis [Completed]

Pharmacokinetic Properties of Two Dosages Nevirapine Extended Release (XR) Formulations Compared to VIRAMUNE« Tablet as Well as to Nevirapine XR Tablet in Healthy Male Volunteers [Completed]

Genotype Based Personalized Prescription of Nevirapine [Completed]

Study on the Effect of Kaletra + Nevirapine as Maintenance Bitherapy Compared to a Triple Therapy Including Kaletra + Analogues in HIV Patients [Completed]

Study to Evaluate the Replacement of Reverse Transcriptase Nucleoside/Nucleotide Inhibitors by Nevirapine in Patients on Triple Treatment With Analogues Only [Completed]

Pharmacoscintigraphic Investigation Into the Absorption of Nevirapine When Released Into Different Parts of the Gastro-intestinal Tract in Healthy Males [Completed]

Efavirenz-based Versus Nevirapine-based Antiretroviral Therapy Among HIV-infected Patients Receiving Rifampin [Completed]

Multiple Dose BE Study With Nevirapine 400mg PR Tablets [Active, not recruiting]

Drug Interaction Between Coartem« and Nevirapine, Efavirenz or Rifampicin in HIV Positive Ugandan Patients [Active, not recruiting]

Nevirapine Dosing in Neonates for Prophylaxis of Mother-to-Child-Transmission (MTCT) of HIV Infection [Recruiting]

Observational Study in Patients With HIV Infection Type 1 After Switching to a Viramune«-Containing Therapy Regimen [Completed]

Optimizing Pediatric HIV-1 Treatment in Infants With Prophylactic Exposure to Nevirapine, Nairobi, Kenya [Terminated]

Long-term Study in Patients Under Anti-retroviral Combination Therapy Switching to Viramune« [Completed]

Study to Evaluate the Influence of Nevirapine to Atazanavir in Steady State Equilibrium in HIV Patients [Completed]

Daily Nevirapine to Prevent Mother to Infant Transmission of HIV [Completed]

Investigation of the Potential Pharmacokinetic Interaction Between Nevirapine, Abacavir and Amprenavir in HIV-1 Infected Non-Nucleoside Reverse Transcriptase Inhibitor (NNRTI) Naive Adults [Terminated]

Influence of Nevirapine on HCV Viral Load [Not yet recruiting]

Triomune Bioequivalence With Innovators [Completed]

Study of Nevirapine and Prednisone to Determine the Safety and Effectiveness in Preventing Nevirapine Associated Rash in Human Immunodeficiency Virus (HIV) Infected Patients [Completed]

Bioavailability of 2 Different Nevirapine Extended Release Formulations Compared to Viramune« in HIV-1 Infected Subjects [Completed]

Nevirapine Study for the Prevention of Maternal-Infant HIV Transmission in Uganda [Completed]

Relative Bioavailability of Different Oral Viramune Extended Release Formulations Compared to Viramune« Oral Suspension in Healthy Male Volunteers [Completed]

An Open-Label, Non-Randomized Trial to Evaluate the Tolerability and Safety of Viramune (Nevirapine) in Adult and Pediatric Patients With Progressive HIV Disease [Completed]

Observational Study With Antiretroviral Treated Patients Switching to Nevirapine Plus Two Nucleoside Reverse Transcriptase Inhibitor (NRTI) Regimens [Completed]

ATV/Ritonavir Nevirapine Interaction (USPAC) [Completed]

Case-Control Viramune (Nevirapine) Toxicogenomics Study [Completed]

A Pharmacokinetic Study to Assess Nevirapine [Viramune] Levels in HIV Infected Patients With Impaired Hepatic Functions [Completed]

An Open-Label Study in HIV+ Patients to Determine the Effects of Nevirapine (Viramune) on the Pharmacokinetics of Clarithromycin and Activity of Cytochrome 3A4. [Completed]

Pharmacokinetic Study of Interaction Between Nevirapine and Methadone in HIV-1 Infected, Opioid-dependent Adults [Completed]

Rifampin and Nevirapine Interactions in Young Children [Recruiting]

Evaluation of Renal Function, Efficacy, and Safety When Switching From Tenofovir/Emtricitabine Plus a Protease Inhibitor/Ritonavir, to a Combination of Raltegravir (MK-0518) Plus Nevirapine Plus Lamivudine in HIV-1 Participants With Suppressed Viremia and Impaired Renal Function (MK-0518-284) [Recruiting]

A Study to Evaluate the Effects of Genetic Factors on the Pharmacokinetics of Antiretroviral Drugs During Pregnancy and Lactation [Completed]

Pharmacokinetic Evaluation of Changes in Nevirapine AUC Due to Differences in Weight [Completed]

Genetic Determinants of the Metabolism of Non-nucleoside Reverse Transcriptase Inhibitors [Completed]

The Safety and Effectiveness of Nevirapine Plus Lamivudine Plus Other Anti-HIV Drugs [Completed]

Safety and Pharmacokinetic Study of Fixed Dose Combination of Zidovudine, Lamivudine, and Nevirapine in HIV-Infected Children in Thailand [Completed]

Study to Determine the Effects of Nevirapine (VIRAMUNE´┐Ż) on the Steady State Pharmacokinetics of Rifabutin (MYCOBUTIN«) in HIV+ Patients [Completed]

Nevirapine (NVP) Use to Prevent Mother-to-Child Transmission of HIV [Completed]

Efficacy Safety Study Comparing 2 Doses of NVP After Initiating Rifampin-containing TB Therapy [Completed]

Switching Nevirapine Immediate Release( IR) Based Regimen to Nevirapine Extended Release (XR) Based Regimen in Human Immunodeficiency Virus One (HIV-1) Infected Patients [Completed]

The Safety and Effectiveness of Nevirapine Plus Nelfinavir in HIV-1 Infected Patients Who Have Taken Stavudine [Completed]

Non-interventional Observational Study With Viramune (Nevirapine) and Various Drug Combinations in the Antiretroviral Combination Treatment of HIV-infected Patients Who Have Already Been Treated for Approx. 10 Years With Viramune [Completed]

TMC207-TiDP13-C117: Interaction Study in Human Immunodeficiency Virus-type 1 (HIV-1) Infected Patients With Nevirapine (NVP) [Completed]

Trial of Three Neonatal Antiretroviral Regimens for Prevention of Intrapartum HIV Transmission [Completed]

Pharmacokinetic Interaction Between Nevirapine and Saquinavir-sgc in HIV-1 Infected Patients [Terminated]

A Pharmacokinetic Evaluation of Levonorgestrel Implant and Antiretroviral Therapy [Active, not recruiting]

Nevirapine or Atazanavir/Ritonavir Given With Emtricitabine/Tenofovir in Human Immunodeficiency Virus (HIV)-1-infected Treatment Naive Adults [Completed]

Pharmacokinetic Properties of Nevirapine Extended Release Tablets When Administered Orally in Healthy Male Volunteers [Completed]

Comparison of Nevirapine and Efavirenz for the Treatment of HIV-TB Co-infected Patients (ANRS 12146 CARINEMO) [Completed]

Study to Evaluate the Effects of Underlying Renal or Hepatic Dysfunction on the Pharmacokinetics of Nevirapine [Completed]

Effects of Nevirapine on the Steady State Pharmacokinetics of Fluconazole in HIV Positive Patients [Completed]

Durability of Nevirapine-Based Antiretroviral Regimen [Completed]

An Open-Label, Pilot Study to Evaluate the Development of Resistance to Nevirapine (BI-RG-587) in HIV-Infected Patients With CD4 Cell Count >= 500/mm3 [Completed]

A Study of Nevirapine Used Alone or in Combination With AZT in HIV-1-Infected Children [Completed]

The Safety and Effectiveness of BI-RG-587 in HIV-Infected Patients [Completed]

Trial About Hepatic Security of Antiretroviral Treatment Based on Kaletra Versus Nevirapine in co-Infected HIV/HCV Patients [Terminated]

A Phase I Study of Safety and Pharmacokinetics of Nevirapine in HIV-1 Infected Pregnant Women and Neonates Born to HIV-1 Infected Mothers [Completed]

An Open-Label, Staggered Rising Dose Cohort Study Assessing the Pharmacokinetics, Safety, and Tolerance of BI-RG-587 in Combination With Zidovudine in Patients With HIV Infection (CD4+ Cell Count < 400/mm3) [Completed]

A Comparative Study of a Combination of Zidovudine, Didanosine, and Double-Blinded Nevirapine Versus a Combination of Zidovudine and Didanosine [Completed]

Zidovudine / Lamivudine + Nevirapine Twice Daily, Versus Tenofovir + Lamivudine + Nevirapine Once Daily in ARV-Naive Patients [Recruiting]

Antiviral Responses to NNRTI-Based vs. PI-Based ARV Therapy in HIV Infected Infants Who Have or Have Not Received Single Dose NVP for Prevention of Mother-to-Child Transmission of HIV [Active, not recruiting]

The Safety and Effectiveness of Nevirapine and Zidovudine, Given Separately and Together, in HIV-1 Infected Patients Who Have No Symptoms of the Disease [Completed]

Artemether/Lumefantrine and Nevirapine Interaction Study in HIV-infected Adults [Completed]

Efavirenz to Nevirapine Switch and Low-Density Lipoprotein (LDL)-Dyslipidemia [Completed]

A Multi-Center, Placebo-Controlled, Double-Blind, Randomized Trial Comparing the Virologic and Immunologic Activities of 400 Mg Nevirapine in Combination With Zidovudine Versus Zidovudine Alone in Asymptomatic HIV-1 Infected Patients With 4-12 Months of Prior Zidovudine Therapy and 200-500 CD4+ Cell [Completed]

A Study of Nevirapine to Prevent HIV Transmission From Mothers to Their Babies [Completed]

A Study of Nevirapine for the Prevention of HIV Transmission From Mothers to Their Babies [Completed]

A Study of Nevirapine to Prevent HIV Transmission From Mothers to Their Infants [Completed]

The Effect of Phenytoin on the Pharmacokinetics of Nevirapine and the Development of Nevirapine Resistance [Completed]

The Safety of Nevirapine When Given to Breast-Feeding Babies From Birth to Age 6 Months [Completed]

Efficacy of Nevirapine Compared to ZDV + 3TC Administered in Labor and Again at Postdelivery in HIV Positive Women [Completed]

Effectiveness of AZT and Nevirapine in Preventing HIV Transmission From Ugandan Mothers to Their Newborns [Completed]

The Safety and Effectiveness of Retrovir Plus HIVID Combined With Either Nevirapine or Invirase in the Treatment of HIV Infection [Completed]

A Two Year Study of the Clinical Efficacy of the Combination of Emtricitabine, Tenofovir, and Nevirapine [Completed]

Nevirapine vs. Atazanavir Boosted With Ritonavir on a Background of Truvada in Human Immunodeficiency Virus (HIV) Infected Naive Patients (NEwArT) [Completed]

Observational Study of Nevirapine Extended Release in Human Immunodeficiency Virus (HIV) Patients in Daily Clinical Practice [Completed]

Comparison of Plasma Drug Levels of Triomune 40 With Those of the Originator Products [Completed]

A Study of Single Dose Nevirapine (NVP) Combined With Combivir« for the Prevention of Mother to Child Transmission (pMTCT) - Treatment Options Preservation Study (TOPS) [Completed]

Using Nevirapine to Prevent Mother-to-Child HIV Transmission During Breastfeeding [Completed]

Drug Levels of Tablet and Liquid Forms of Lamivudine, Nevirapine, and Stavudine in HIV Infected Thai Children [Completed]

The Safety and Effectiveness of Didanosine Plus Stavudine Plus Nevirapine Combined With MKC-442 in HIV-Infected Patients Who Have Not Had Success With Protease Inhibitors [Terminated]

Quality of Life and Changes in Metabolism of Lipids and Glucose After Switching to a Nevirapine-based Regimen in HIV+ Patients [Completed]

A Study of Zidovudine/Lamivudine and Either Nevirapine or Nelfinavir for Reduction of Mother-to-child HIV Transmission During Breastfeeding [Active, not recruiting]

Nevirapine Levels and Fluconazole [Completed]

Three Generic Nevirapine-Based Antiretroviral Treatments in Chinese Patients:Multicentric Observation Cohort [Completed]

Pediatric Nevirapine Resistance Study [Recruiting]

A Pilot Study of the Immunologic Reconstitution in HIV-1 Infected Children Receiving Highly Active Antiretroviral Therapy With Combination Ritonavir, Nevirapine and Stavudine [Completed]

PI or NNRTI as First-line Treatment of HIV in West Africa - the PIONA Trial [Completed]

Switch From Nevirapine-based Regimen to Once a Day Rilpivirine/Emtricitabine/Tenofovir [Active, not recruiting]

Breastfeeding, Antiretroviral, and Nutrition Study [Completed]

NNRTI vs PI Regimens for HIV Infected Women After They Have Taken Nevirapine to Prevent Mother-To-Child HIV Transmission [Completed]

Nevirapine Plus Zidovudine to Prevent Perinatal HIV in Thailand [Completed]

-- advertisement -- The American Red Cross
Home | About Us | Contact Us | Site usage policy | Privacy policy

All Rights reserved - Copyright DrugLib.com, 2006-2015